Aug 21, 2025, 14:59
Primary APS: Warfarin INR 2.5–3.5 Lowers Thrombosis Recurrence, Especially Arterial Events
APS Support UK has shared a post on X:
“Study of 81 pts with primary APS on warfarin found those with INR 2.5–3.5 had reduced rethrombosis risk vs INR <2.5, esp. for arterial events.
Higher anticoagulation intensity = lower recurrence risk.”
Title: Recurrence of thrombosis in patients with primary antiphospholipid syndrome: Emphasis on arterial events
Authors: Antonio R Cabral, Alonso Turrent-Carriles, Irazu Contreras-Yáñez, Ariel Garcia-Torralba, Gabriela Hernandez-Molina
Read the full article here.
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin